RESUMEN
The Diabetic Retinopathy Clinical Research Network (DRCR.net) performs studies on new treatments for diabetic retinopathy. This review aims to summarise recent findings from DRCR.net studies on the treatment of diabetic macular oedema. We performed a PubMed search of articles from the DRCR.net, which included all studies pertaining to the treatment of diabetic maculopathy. The main outcome measures were retinal thickening as assessed by central subfield thickness on optical coherence tomography and improvement of visual acuity on the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. Findings from each study were divided into modalities of treatment, namely photocoagulation, bevacizumab, triamcinolone, ranibizumab and vitrectomy. While modified ETDRS focal/grid laser remains the standard of care, intravitreal corticosteroids or anti-vascular endothelial growth factor agents have also proven to be effective, although they come with associated side effects. The choice of treatment modality for diabetic macular oedema is a clinical judgement call, and depends on the patient's clinical history and assessment.
Asunto(s)
Humanos , Corticoesteroides , Usos Terapéuticos , Bevacizumab , Usos Terapéuticos , Investigación Biomédica , Retinopatía Diabética , Terapéutica , Manejo de la Enfermedad , Progresión de la Enfermedad , Fotocoagulación , Edema Macular , Terapéutica , Ranibizumab , Usos Terapéuticos , Retina , Patología , Tomografía de Coherencia Óptica , Triamcinolona , Usos Terapéuticos , Factor A de Crecimiento Endotelial Vascular , Agudeza Visual , VitrectomíaRESUMEN
The primary aim of this study is to report the outcome of patients with rhegmatogenous retinal detachment [RRD] who underwent scleral buckling [SB] surgery. This is a retrospective noncomparative case series study of all patients who underwent RRD repair by primary SB between March 2008 and February 2009. Patient demographics, visual outcome, complications, and failure rates were identified and recorded. A total of 65 patients underwent RRD repair by SB, with a mean age of 44.44 years. Results showed that the primary outcome [primary anatomical success following index surgery] was 90.77%, while the secondary outcome [anatomical success following repeat surgery] was 98.46%. The study showed a high-success rate of SB in phakic eyes both in terms of postoperative best-corrected visual acuity and complication rates. We recommend the continued use of this technique in selected cases of RRD